G1 Ther­a­peu­tics joins a grow­ing biotech win­ners cir­cle with $105M IPO

G1 Ther­a­peu­tics is now the lat­est in a string of biotech IPOs to start out with a hit on its price range. The Re­search Tri­an­gle Park, NC-based out­fit raised $105 mil­lion by sell­ing 7 mil­lion shares at $15 each. That’s the bot­tom of the range, but that qual­i­fies as an­oth­er suc­cess­ful out­ing for the lat­est in a slate of biotechs find­ing a rel­a­tive­ly warm re­cep­tion on Wall Street af­ter a fair­ly chilly Q1.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.